A new study warns that common anti-inflammatory drugs might leave patients vulnerable to severe viral infections.

While there was more risk, most studies couldn't disentangle the effects of childhood adversity from other factors that may ...

The biotech startup, a spinout of the University of Colorado Anschutz Medical Campus, launched this year with $15 million in ...

On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the ...

Autoimmune arthritis, where the immune system attacks joints, presents early signs like morning stiffness exceeding 30 ...

Exposure to the sun's light can be both beneficial and harmful. New research has suggested new uses for light therapy beyond ...

Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, ...

Vitamin D supplements are mostly recommended when you’re deficient. In the U.S., 35% of adults are vitamin D deficient, ...

The mechanisms governing immune-related adverse events resulting from checkpoint inhibition therapy for cancer remain a ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...

Patients with systemic sclerosis or Sjögren's syndrome suffer from various inflammatory reactions triggered by the body's own ...

A shocking new study out of Norway has revealed a popular class of medications can make it easier to catch Covid and the flu.